FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
12-23-2019, 03:09 PM | #1 | |||
|
||||
Grand Magnate
|
Many drug related notices . . .
The United States Patent and Trademark Office Gave METP Pharma US Patent Treating Demyelinating as well as Neuroinflammatory Diseases The United States Patent and Trademark Office gave MetP Pharma US Patent treating Demyelinating, as well as, Neuroinflammatory Diseases-Industry Global News24 Tiglutik FDA Approves New Indication for Tiglutik for ALS FDA Approves New Indication for Tiglutik for ALS - Specialty Pharmacy Continuum FDA Approves Broader Label for ALS Drug, Riluzole FDA Approves Broader Label for ALS Drug, Riluzole | Managed Care magazine Amylyx (AMX0035) ALS Drug Works in Study, Researchers Say ALS Drug Works in Study, Researchers Say - WSJ Amylyx drug helps slow ALS progression in mid-stage study Amylyx drug helps slow ALS progression in mid-stage study | News | WKZO ALS Researchers Concoct New Drug to Help Slow Progression of Lou Gehrig’s Disease https://sputniknews.com/society/2019...hrigs-disease/ ALS drug ‘significantly’ slows disease progression in late-stage trial https://www.mcknights.com/news/clini...e-stage-trial/ Reldesemtiv Cytokinetics' reldesemtiv an Orphan Drug in U.S. https://seekingalpha.com/news/352703...an-drug-in-u-s miR-218 ALS Genomic Analysis Highlights Potential MicroRNA Contributor https://www.genomeweb.com/sequencing...na-contributor MSC-NTF cells (NurOwn) BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in Neurology https://dodsondigest.com/brainstorm-...-in-neurology/ Ionis licenses investigational Alzheimer's therapy https://finance.yahoo.com/news/ionis...120500216.html Arimoclomol and Aldoxorubicin CytRx Corporation Highlights Significant Positive Events From its Two Licensed Drugs Arimoclomol and Aldoxorubicin https://www.prnewswire.com/news-rele...300977445.html Google’s A.I. "Project Euphonia" The never-ending war against ALS gains a weapon in technology https://www.clnsmedia.com/never-endi...on-technology/ Thought to speech Meet the Neuroscientist Translating Brain Activity Into Speech https://www.discovermagazine.com/min...ty-into-speech Is Rolls Royce Giving Voice To ALS (Amyotrophic Lateral Sclerosis) Patients With New AI Tech? https://www.edtimes.in/is-rolls-royc...h-new-ai-tech/ medical marijuana Getting a medical marijuana card is easier than ever — and it could help you avoid lines, save money when recreational sales start https://chicago.suntimes.com/cannabi...s-recreational AstroRx® cells Kadimastem Announces the Completion of Treatment for Cohort B of Its Phase 1/2a Clinical Trial in ALS Patients https://www.prnewswire.com/news-rele...300979013.html Roche hands $1B to Sarepta in major return to gene therapy deals https://www.biopharmadive.com/news/r...y-deal/569599/ This is the largest set of year-end research disclosures I have ever seen. Not big fan of this year, kind-a-glad its almost over but nice to seen bunch of this sort of news. |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Job applications and disclosures about absence. Help!? | Traumatic Brain Injury and Post Concussion Syndrome |